Marker Therapeutics Inc (MRKR) — Cash Flow-to-Debt Ratio
Marker Therapeutics Inc (MRKR) has a Cash Flow-to-Debt Ratio of -0.39x as of March 2026, meaning its operating cash flow of $-1.40 Million could theoretically repay 0% of its total liabilities ($3.64 Million) in one year. See MRKR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Marker Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Marker Therapeutics Inc across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does Marker Therapeutics Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Marker Therapeutics Inc (1999–2025)
Year-by-year debt coverage analysis for Marker Therapeutics Inc. Check MRKR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.28x | $-12.01 Million | $2.27 Million | ▼ -67.7% |
| 2024 | -3.15x | $-10.91 Million | $3.46 Million | ▲ +41.1% |
| 2023 | -5.35x | $-16.44 Million | $3.07 Million | ▼ -193.8% |
| 2022 | -1.82x | $-26.97 Million | $14.82 Million | ▼ -61.1% |
| 2021 | -1.13x | $-27.28 Million | $24.15 Million | ▼ -3.0% |
| 2020 | -1.10x | $-20.03 Million | $18.27 Million | ▲ +86.4% |
| 2019 | -8.04x | $-18.28 Million | $2.27 Million | ▼ -55.7% |
| 2018 | -5.16x | $-14.48 Million | $2.80 Million | ▲ +6.8% |
| 2017 | -5.54x | $-8.44 Million | $1.52 Million | ▼ -47.9% |
| 2016 | -3.75x | $-6.51 Million | $1.74 Million | ▼ -2316.8% |
| 2015 | -0.16x | $-4.34 Million | $28.01 Million | ▲ +91.1% |
| 2014 | -1.75x | $-2.19 Million | $1.25 Million | ▼ -2131.6% |
| 2013 | -0.08x | $-694.58K | $8.85 Million | ▲ +71.0% |
| 2012 | -0.27x | $-1.57 Million | $5.77 Million | ▲ +21.3% |
| 2011 | -0.34x | $-1.31 Million | $3.80 Million | ▼ -26.3% |
| 2010 | -0.27x | $-925.04K | $3.39 Million | ▲ +76.0% |
| 2009 | -1.14x | $-1.12 Million | $986.35K | ▼ -389.7% |
| 2008 | -0.23x | $-714.42K | $3.08 Million | ▲ +63.0% |
| 2007 | -0.63x | $-1.23 Million | $1.95 Million | ▼ -66.9% |
| 2006 | -0.38x | $-1.19 Million | $3.15 Million | ▲ +25.5% |
| 2005 | -0.50x | $-1.16 Million | $2.31 Million | ▼ -4.9% |
| 2004 | -0.48x | $-1.21 Million | $2.53 Million | ▲ +86.3% |
| 2003 | -3.52x | $-2.59 Million | $736.95K | ▲ +26.1% |
| 2002 | -4.76x | $-1.41 Million | $295.60K | ▼ -34741.2% |
| 2001 | 0.01x | $2.38K | $173.03K | ▲ +101.1% |
| 2000 | -1.29x | $-879.74K | $682.74K | ▲ +54.2% |
| 1999 | -2.81x | $-815.18K | $289.71K | — |